CompoAtlas

Sleep Formula

Natural health product licensed in Canada

Licence holder
Stalco Inc.
NPN or DIN-HM
80082982
Status
Inactive licence
Licence date
8 February 2018
Revision date
13 August 2018
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Passiflora incarnata

Source : Sommité

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 240 mg

60 mgNot calculated
Phellodendron amurense

Source : Écorce (tige)

50 mgNot calculated
Melissa officinalis

Source : Sommité

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 240 mg

60 mgNot calculated
N-acétyl-5-méthoxytryptamine

Source : Mélatonine

1 mgNot calculated
L-théanine

Source : L-Théanine

50 mgNot calculated
Magnolia officinalis

Source : Écorce (tige)

100 mgNot calculated
Scutellaria lateriflora

Source : Sommité

Extract : Matériel brut sec

Extraction ratio : 4.167:1

Dry plant equivalent : 250 mg

60 mgNot calculated
5-Hydroxy-L-tryptophane

Source : Griffonia simplicifolia, graine

50 mgNot calculated
5-Hydroxy-L-tryptophane

Source : 5-HTP

50 mgNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Cellulose microcristalline, Eau

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps to prevent and/or reduce the effects of jet lag (e.g. daytime fatigue, sleep disturbance) for people travelling by plane easterly across two or more time zones. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm). .

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80082982

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line